Carson Wealth (CWM LLC)
ALNY icon

Carson Wealth (CWM LLC)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.83M Sell
11,580
-13,895
-55% -$4.73M 0.01% 925
2025
Q4 		$10.1M Sell
25,475
-3,812
-13% -$1.69M 0.03% 526
2025
Q3 		$13.4M Buy
29,287
+23,775
+431% +$9.68M 0.04% 379
2025
Q2 		$1.8M Sell
5,512
-11,152
-67% -$3.09M 0.01% 992
2025
Q1 		$4.5M Buy
16,664
+3,473
+26% +$893K 0.02% 558
2024
Q4 		$3.1M Buy
13,191
+6,427
+95% +$1.69M 0.01% 610
2024
Q3 		$1.86M Buy
6,764
+3,272
+94% +$852K 0.01% 737
2024
Q2 		$849K Buy
3,492
+1,770
+103% +$279K ﹤0.01% 983
2024
Q1 		$257K Sell
1,722
-41,678
-96% -$6.95M ﹤0.01% 1398
2023
Q4 		$8.31M Sell
43,400
-538
-1% -$91.6K 0.04% 295
2023
Q3 		$7.78M Sell
43,938
-1,436
-3% -$274K 0.05% 280
2023
Q2 		$8.62M Buy
45,374
+43,648
+2,529% +$8.65M 0.05% 249
2023
Q1 		$346K Sell
1,726
-193
-10% -$40.6K ﹤0.01% 1013
2022
Q4 		$456K Sell
1,919
-1,044
-35% -$223K ﹤0.01% 837
2022
Q3 		$593K Sell
2,963
-410
-12% -$78.2K ﹤0.01% 702
2022
Q2 		$492K Sell
3,373
-6,579
-66% -$933K ﹤0.01% 737
2022
Q1 		$1.63M Sell
9,952
-2,046
-17% -$312K 0.01% 444
2021
Q4 		$2.04M Buy
+11,998
New +$2.23M 0.01% 428
2021
Q2 		$2.02M Hold
11,896
– – 0.02% 423
2021
Q1 		$2.02M Hold
11,896
– – 0.02% 423
2020
Q4 		$2.02M Hold
11,896
– – 0.02% 423
2020
Q3 		$2.02M Hold
11,896
– – 0.02% 423
2020
Q2 		$2.02M Hold
11,896
– – 0.02% 423
2020
Q1 		$2.02M Hold
11,896
– – 0.02% 423
2019
Q4 		$2.02M Hold
11,896
– – 0.02% 423
2019
Q3 		$2.02M Hold
11,896
– – 0.02% 423
2019
Q2 		$2.02M Hold
11,896
– – 0.02% 423
2019
Q1 		$2.02M Buy
+11,896
New +$995K 0.02% 423

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ALNY Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Alnylam Pharmaceuticals (ALNY) stake by 55% in Q1 2026, selling an estimated $4.73M and leaving 11,580 shares worth $3.83M. The position accounts for 0.01% of the portfolio, ranked #925.

Carson Wealth (CWM LLC) first reported a position in ALNY in Q1 2019 and has held it in 28 quarters since. The position peaked at $13.4M in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Carson Wealth (CWM LLC) held 11,580 shares of Alnylam Pharmaceuticals worth $3.83M as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 13,895 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $4.73M.
  • Alnylam Pharmaceuticals made up 0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #925 holding.
  • Carson Wealth (CWM LLC) first reported a position in Alnylam Pharmaceuticals in Q1 2019 and has held it in 28 quarters since.
  • Carson Wealth (CWM LLC)'s Alnylam Pharmaceuticals position peaked at $13.4M in Q3 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.